Mining the CCGD database revealed that Tm9sf2 was a transposon-targeted mutation in an additional eight forward genetic screens, including screens for liver, pancreatic, breast, and gastric cancer (see Supplementary Table S2). The gene discussed is TM9SF2; the disease is gastric cancer.